The 62nd Annual Meeting and Exposition of the American Society of Hematology (ASH) was originally to be held in San Diego, California. This year it will be presented as an all-virtual event - given the continuing threat of the COVID-19 pandemic - on 5 to 8 December, providing attendees with access to an innovative virtual meeting platform built for learning, collaboration, and networking.

Purpose of ASH meetings

The mission of the ASH is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training and advocacy in hematology. In accordance with this mission, the primary purpose of scientific meetings organized by ASH, including the Society’s annual meeting, is to facilitate the exchange of scientific information and clinical results related to the field of hematology. Another important goal of ASH-organized meetings is to assist physicians and scientists in developing and maintaining academic collaborations that will generate new knowledge, ultimately benefiting patients.

Educational objectives

Upon completion, participants of the meeting should be able to:

• Employ the knowledge gained regarding the diagnosis and treatment of benign and malignant hematologic disorders to improve patient care;
• Discuss state-of-the-art research in hematology; and
• Analyze the potential contribution of novel, not-yet-approved modalities of therapy to current evidence-based management of hematologic disorders.

E-newsletters

CongressUpdate Hematology provides you with a selection of the most important highlights of the ASH Annual Meeting and Exposition by means of summaries of lectures, key slides and podcasts with opinions of top clinicians that support your daily management of hematologic patients.